Sio Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-120,198
| Closed | -$871K | – | 55 |
|
|
2023
Q1 | $871K | Hold |
120,198
| – | – | 0.43% | 33 |
|
|
2022
Q4 | $1.35M | Sell |
120,198
-66,543
| -36% | -$748K | 0.5% | 24 |
|
|
2022
Q3 | $2.46M | Hold |
186,741
| – | – | 0.78% | 19 |
|
|
2022
Q2 | $2.36M | Buy |
186,741
+151,897
| +436% | +$1.92M | 0.89% | 29 |
|
|
2022
Q1 | $2M | Buy |
34,844
+14,904
| +75% | +$857K | 0.66% | 33 |
|
|
2021
Q4 | $2.37M | Buy |
19,940
+2,100
| +12% | +$249K | 0.71% | 39 |
|
|
2021
Q3 | $3.55M | Buy |
17,840
+1,734
| +11% | +$345K | 1.13% | 29 |
|
|
2021
Q2 | $2.8M | Hold |
16,106
| – | – | 0.7% | 44 |
|
|
2021
Q1 | $3.19M | Buy |
16,106
+8,462
| +111% | +$1.68M | 0.65% | 49 |
|
|
2020
Q4 | $1.5M | Sell |
7,644
-800
| -9% | -$157K | 0.31% | 71 |
|
|
2020
Q3 | $1.5M | Hold |
8,444
| – | – | 0.3% | 64 |
|
|
2020
Q2 | $1.95M | Buy |
+8,444
| New | +$1.95M | 0.57% | 46 |
|
|
2017
Q4 | – | Sell |
-5,183
| Closed | -$639K | – | 56 |
|
|
2017
Q3 | $639K | Hold |
5,183
| – | – | 0.33% | 36 |
|
|
2017
Q2 | $499K | Sell |
5,183
-1,613
| -24% | -$155K | 0.24% | 37 |
|
|
2017
Q1 | $1.27M | Sell |
6,796
-743
| -10% | -$138K | 0.71% | 26 |
|
|
2016
Q4 | $820K | Buy |
7,539
+1,366
| +22% | +$149K | 0.48% | 25 |
|
|
2016
Q3 | $989K | Buy |
6,173
+498
| +9% | +$79.8K | 0.68% | 24 |
|
|
2016
Q2 | $690K | Buy |
+5,675
| New | +$690K | 0.35% | 27 |
|